INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/12/2026
Back to search
Official data from USPTO
RHAPSIDO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
08/12/2026
Trademark type
Word
Nice classes
5
Filing date
09/26/2018
Registration date
05/28/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/12/2025
Last transaction
08/12/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
ABRAMS, JACQUELINE WILLETTE
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
33 publications found
C71T
CANCELLED SECTION 71
12/12/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/28/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/24/2022
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
09/27/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/12/2019
FIMP
FINAL DISPOSITION PROCESSED
09/12/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/28/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
05/28/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2019
PUBO
PUBLISHED FOR OPPOSITION
03/12/2019
GPNX
NOTIFICATION PROCESSED BY IB
03/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/20/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/20/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/20/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/05/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2019
ALIE
ASSIGNED TO LIE
02/02/2019
RFNT
REFUSAL PROCESSED BY IB
02/01/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/29/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/23/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/23/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/15/2019
RFRR
REFUSAL PROCESSED BY MPU
01/15/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/01/2019
CNRT
NON-FINAL ACTION WRITTEN
12/31/2018
DOCK
ASSIGNED TO EXAMINER
12/31/2018
MAFR
APPLICATION FILING RECEIPT MAILED
12/18/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/14/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/07/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
12/06/2018
Continuous trademark protection
Get notified about every new filing that threatens RHAPSIDO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.